Zuo X - Search Results

1

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma.

Sun R, Wang X, Chen J, Teng D, Chan S, Tu X, Wang Z, Zuo X, Wei X, Lin L, Zhang Q, Zhang X, Tang K, Zhang H, Chen W. Sun R, et al. Among authors: zuo x. Front Genet. 2022 Sep 6;13:949110. doi: 10.3389/fgene.2022.949110. eCollection 2022. Front Genet. 2022. PMID: 36147502 Free PMC article.

2

Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.

Kong W, Zuo X, Liang H, Hu J, Zhang H, Wang X, Chen W. Kong W, et al. Among authors: zuo x. Biomed Res Int. 2018 Dec 27;2018:1723184. doi: 10.1155/2018/1723184. eCollection 2018. Biomed Res Int. 2018. PMID: 30687735 Free PMC article.

3

Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma.

Zuo X, Kong W, Feng L, Zhang H, Meng X, Chen W. Zuo X, et al. Cancer Biomark. 2019;24(3):307-313. doi: 10.3233/CBM-182076. Cancer Biomark. 2019. PMID: 30829614

4

Mean corpuscular hemoglobin concentration correlates with prognosis of resected hepatocellular carcinoma.

Kong W, Zheng J, Chen L, Zuo X, Wang H, Wang X, Yao J, Chen W. Kong W, et al. Among authors: zuo x. Biomark Med. 2020 Mar;14(4):259-270. doi: 10.2217/bmm-2019-0224. Epub 2020 Mar 5. Biomark Med. 2020. PMID: 32134324

5

Diagnostic value of HOX transcript antisense RNA for cancer detection: a meta-analysis.

Kong W, Yang M, Zhu Y, Zuo X, Wang H, Chen W. Kong W, et al. Among authors: zuo x. Biomark Med. 2020 Apr;14(5):401-411. doi: 10.2217/bmm-2019-0207. Epub 2020 Apr 9. Biomark Med. 2020. PMID: 32270696

6

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma.

Kong W, Wang X, Zuo X, Mao Z, Cheng Y, Chen W. Kong W, et al. Among authors: zuo x. Front Genet. 2020 Sep 4;11:1037. doi: 10.3389/fgene.2020.01037. eCollection 2020. Front Genet. 2020. PMID: 33101369 Free PMC article.

7

LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.

Kong W, Wu Z, Yang M, Zuo X, Yin G, Chen W. Kong W, et al. Among authors: zuo x. IUBMB Life. 2020 Dec;72(12):2672-2685. doi: 10.1002/iub.2408. Epub 2020 Nov 19. IUBMB Life. 2020. PMID: 33211382 Free article.

8

PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.

Wang X, Sun R, Chan S, Meng L, Xu Y, Zuo X, Wang Z, Hu X, Han Q, Dai L, Bai T, Yu Z, Wang M, Yang W, Zhang H, Chen W. Wang X, et al. Among authors: zuo x. Front Genet. 2022 Sep 14;13:955355. doi: 10.3389/fgene.2022.955355. eCollection 2022. Front Genet. 2022. PMID: 36186438 Free PMC article.

9

A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer.

Wang X, Xu Y, Dai L, Yu Z, Wang M, Chan S, Sun R, Han Q, Chen J, Zuo X, Wang Z, Hu X, Yang Y, Zhao H, Hu K, Zhang H, Chen W. Wang X, et al. Among authors: zuo x. Front Immunol. 2022 Oct 31;13:1043738. doi: 10.3389/fimmu.2022.1043738. eCollection 2022. Front Immunol. 2022. PMID: 36389694 Free PMC article.

10

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer.

Wang X, Zuo X, Hu X, Liu Y, Wang Z, Chan S, Sun R, Han Q, Yu Z, Wang M, Zhang H, Chen W. Wang X, et al. Among authors: zuo x. Front Oncol. 2023 Mar 17;13:927608. doi: 10.3389/fonc.2023.927608. eCollection 2023. Front Oncol. 2023. PMID: 37007145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,015 results

Search Page

Filters